SOPHiA GENETICS Partners with Jessa Ziekenhuis for Genomic Testing in Belgium
SOPHiA GENETICS has announced a significant collaboration with Jessa Ziekenhuis to advance genomic testing and oncology research in Belgium, announced in a press release. This partnership aims to bring cutting-edge genomic testing to cancer patients across the country.
Jessa Ziekenhuis, a major healthcare institution in Belgium, will integrate SOPHiA DDM™ into its pathology operations. This integration will standardize next-generation sequencing (NGS) workflows, enhancing efficiency and compliance with national guidelines. The hospital will implement six SOPHiA GENETICS applications tailored to its needs in solid tumors, hematologic malignancies, and liquid biopsy analysis.
The collaboration is expected to reduce hands-on time by 30-50%, cut costs by up to 25%, and accelerate testing turnaround times. Additionally, the SOPHiA DDM™ Dispatch feature will allow Jessa Ziekenhuis to share a NovaSeq sequencer with AZ Delta in Roeselare, Belgium, optimizing sequencing capacity and knowledge sharing through the Bridge Consortium.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Sophont launches Holon-S1 to predict gene activity from pathology slides
Pathos AI Raises $237 Million at $3 Billion Valuation
INmune Bio and QCi Apply Quantum Computing to XPro Research
Illumina Adds Three Research Tools to BioInsight Platform
Switchpoint Bio raises $5.3 million for AI epigenomics platform
Daily AI Brief: the AI news that matters, in your inbox.